Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction
Author:
Publisher
John Wiley & Sons, Ltd
Link
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009503.pub2/epdf/full
Reference79 articles.
1. High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction;Desmet;European Heart Journal,2011
2. Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial;Fokkema;Circulation. Cardiovascular Interventions,2009
3. New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention;Grygier;The American Journal of Cardiology,2011
4. Ji ZG Han JM Liu G Liu K Effect of adenosine on ischemia-reperfusion injury during percutaneous coronary intervention Journal of Clinical Rehabilitative Tissue Engineering Research 2007 10399 403
5. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction;Marzilli;Circulation,2000
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cardioprotective and Antianginal Efficacy of Nicorandil: A Comprehensive Review;Journal of Cardiovascular Pharmacology;2023-08
2. No-reflow phenomenon and reperfusion injury. Mechanisms and treatment;The Clinician;2022-03-05
3. Post–ST‐Segment–Elevation Myocardial Infarction Platelet Reactivity Is Associated With the Extent of Microvascular Obstruction and Infarct Size as Determined by Cardiac Magnetic Resonance Imaging;Journal of the American Heart Association;2022-02
4. Myocardial preservation during primary percutaneous intervention: It's time to rethink?;Indian Heart Journal;2021-07
5. Drug-induced atrioventricular blockages;Medical alphabet;2020-11-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3